M von Lilienfeld-Toal

CD4⁺CD25⁺FoxP3⁺ regulatory T cells are increased whilst CD3⁺CD4⁻CD8⁻αβTCR⁺ Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden

Sylvia Feyler, M von Lilienfeld-Toal, Sarah Jarmin et al. · British Journal of Haematology · 2009 · 145 citations · Full text

Life Sciences, Hematology, Immunology +11

Activated γδ T cells express the natural cytotoxicity receptor natural killer p44 and show cytotoxic activity against myeloma cells

M von Lilienfeld-Toal, Jacob Nattermann, Georg Feldmann et al. · Clinical & Experimental Immunology · 2006 · 90 citations · Full text

Life Sciences, Cell Biology, Immunology +13

Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program

Kai Hübel, Maximilian M. Fresen, Hans Salwender et al. · Bone Marrow Transplantation · 2010 · 79 citations

Medicine, Oncology, Pharmacotherapy +11

Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells.

Angela Märten, Sabine Renoth, M von Lilienfeld-Toal et al. · PubMed · 2001 · 70 citations

Life Sciences, Cell Biology, Immunology +17

Polymorphisms of Toll-like receptors (TLR2 and TLR4) are associated with the risk of infectious complications in acute myeloid leukemia

Ulf Schnetzke, Bärbel Spies‐Weisshart, Olaposi Yomade et al. · Genes and Immunity · 2014 · 48 citations

Life Sciences, Immunology, Infectious Diseases +16